Central Nervous System Biomarkers Market Size, Share & Industry Analysis, By Biomarker Type (Molecular Biomarkers, Imaging Biomarkers, Electrophysiological & Physiological Biomarkers, and Others), By Application (Disease Diagnosis, Drug Discovery & Development, Disease Risk Assessment, and Others), By Disease Indication (Alzheimer Disease, Parkinson’s Disease, Multiple Sclerosis, Traumatic Brain Injury, and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2026-2034

Last Updated: October 18, 2026 | Format: PDF | Report ID: FBI119462

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 10.6% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Biomarker Type, Application, Disease Indication, End User, and Region
By Biomarker Type	Molecular Biomarkers Imaging Biomarkers Electrophysiological & Physiological Biomarkers Others
By Application	Disease Diagnosis Drug Discovery & Development Disease Risk Assessment Others
By Disease Indication	Alzheimer's Disease Parkinson's Disease Multiple Sclerosis Traumatic Brain Injury Others
By End User	Hospitals & Clinics Diagnostic Laboratories Pharmaceutical & Biotechnology Companies Others
By Region	North America (By Biomarker Type, By Application, By Disease Indication, By End User, and by Country) U.S. (By Application) Canada (By Application) Europe (By Biomarker Type, By Application, By Disease Indication, By End User, and by Country/Sub-region) U.K. (By Application) Germany (By Application) France (By Application) Italy (By Application) Spain (By Application) Scandinavia (By Application) Rest of Europe (By Application) Asia Pacific (By Biomarker Type, By Application, By Disease Indication, By End User, and by Country/Sub-region) China (By Application) Japan (By Application) India (By Application) Australia (By Application) Southeast Asia (By Application) Rest of Asia Pacific (By Application) Latin America (By Biomarker Type, By Application, By Disease Indication, By End User, and by Country/Sub-region) Brazil (By Application) Mexico (By Application) Rest of Latin America (By Application) Middle East & Africa (By Biomarker Type, By Application, By Disease Indication, By End User, and by Country/Sub-region) GCC (By Application) South Africa (By Application) Rest of Middle East & Africa (By Application)